Condition: Heart Failure · Sponsor: Novo Nordisk A/S
This study will look into how CDR132L (a potential new medicine) works on the structure and function of the heart in people living with heart failure. Participants will either get CDR132L or placebo (a medicine which has no effect on the body), which treatment the participants get is decided by chance. The study will last for about 60 weeks.
This description comes directly from the study's public registry record.
Novo Nordisk · (+1) 866-867-7178 · clinicaltrials@novonordisk.com
Always discuss trial participation with your own doctor first.
| Concord Repatriation General Hospital - Cardiology Department | Concord, New South Wales, Australia | Recruiting |
| The Prince Charles Hospital | Brisbane, Queensland, Australia | Not Yet Recruiting |
| Royal Adelaide Hospital - Cardiology Department | Adelaide, South Australia, Australia | Recruiting |
| Flinders Medical Centre | Bedford Park, South Australia, Australia | Recruiting |
| Royal Hobart Hospital | Hobart, Tasmania, Australia | Recruiting |
| Victorian Heart Hospital | Clayton, Victoria, Australia | Recruiting |
| Fiona Stanley Hospital - Cardiology | Murdoch, Western Australia, Australia | Recruiting |
| Fakultní nemocnice u sv. Anny v Brně | Brno, Czechia | Completed |
| Nemocnice České Budějovice a.s. | České Budějovice, Czechia | Recruiting |
| Fakultní Nemocnice Ostrava | Ostrava-Poruba, Czechia | Recruiting |
| Vseobecna fakultni nemocnice v Praze | Prague, Czechia | Recruiting |
| Pratia Prague, s.r.o | Prague, Czechia | Not Yet Recruiting |
+ 80 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06979375